121 related articles for article (PubMed ID: 36781357)
1. Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes?
Ayabe RI; Paez-Arango N; Estrella JS; Newhook TE; Tzeng CD; Chun YS; Lee S; Javle M; Vauthey JN; Tran Cao HS
HPB (Oxford); 2023 Apr; 25(4):472-480. PubMed ID: 36781357
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy is associated with improved survival in patients undergoing hepatic resection for intrahepatic cholangiocarcinoma.
Sutton TL; Billingsley KG; Walker BS; Enestvedt CK; Dewey EN; Orloff SL; Mayo SC
Am J Surg; 2021 Jun; 221(6):1182-1187. PubMed ID: 33707077
[TBL] [Abstract][Full Text] [Related]
3. NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
Maithel SK; Keilson JM; Cao HST; Rupji M; Mahipal A; Lin BS; Javle MM; Cleary SP; Akce M; Switchenko JM; Rocha FG
Ann Surg Oncol; 2023 Oct; 30(11):6558-6566. PubMed ID: 37368098
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
5. [A Case of an Advanced Intrahepatic Cholangiocarcinoma Effectively Treated by Conversion Surgery after Neoadjuvant Chemotherapy of Gemcitabine, Cisplatin and S-1].
Ogura N; Hoshino M; Hayashi T; Odaira M; Harada H; Hirose S; Funakoshi S
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1665-1667. PubMed ID: 36733169
[TBL] [Abstract][Full Text] [Related]
6. Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
Sahai V; Catalano PJ; Zalupski MM; Lubner SJ; Menge MR; Nimeiri HS; Munshi HG; Benson AB; O'Dwyer PJ
JAMA Oncol; 2018 Dec; 4(12):1707-1712. PubMed ID: 30178032
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
[TBL] [Abstract][Full Text] [Related]
8. Clinical feasibility of curative surgery after nab-paclitaxel plus gemcitabine-cisplatin chemotherapy in patients with locally advanced cholangiocarcinoma.
Choi SH; Kang I; Lee SH; Kang B; Cheon J; Kim DJ; Kim G; Kwon CI; Ko KH; Chon HJ
Surgery; 2023 Feb; 173(2):280-288. PubMed ID: 36435652
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety comparison of neoadjuvant chemotherapy followed by surgery and upfront surgery for treating intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Yang Z; Jiang X
BMC Gastroenterol; 2023 Apr; 23(1):122. PubMed ID: 37046191
[TBL] [Abstract][Full Text] [Related]
10. Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
Ishii M; Itano O; Morinaga J; Shirakawa H; Itano S
PLoS One; 2022; 17(4):e0266707. PubMed ID: 35452492
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study.
Parente A; Kamarajah SK; Baia M; Tirotta F; Manzia TM; Hilal MA; Pawlik TM; White SA; Dahdaleh FS
J Gastrointest Surg; 2023 Apr; 27(4):741-749. PubMed ID: 36749556
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy in resectable cholangiocarcinoma patients.
Wirasorn K; Ngamprasertchai T; Khuntikeo N; Pakkhem A; Ungarereevittaya P; Chindaprasirt J; Sookprasert A
J Gastroenterol Hepatol; 2013 Dec; 28(12):1885-91. PubMed ID: 23829232
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma.
Le Roy B; Gelli M; Pittau G; Allard MA; Pereira B; Serji B; Vibert E; Castaing D; Adam R; Cherqui D; Sa Cunha A
Br J Surg; 2018 Jun; 105(7):839-847. PubMed ID: 28858392
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment.
Ishimoto U; Kondo S; Ohba A; Sasaki M; Sakamoto Y; Morizane C; Ueno H; Okusaka T
Oncology; 2018; 94(2):72-78. PubMed ID: 29017161
[TBL] [Abstract][Full Text] [Related]
15. The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis.
Buettner S; Koerkamp BG; Ejaz A; Buisman FE; Kim Y; Margonis GA; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JN; Pawlik TM
J Surg Oncol; 2017 Mar; 115(3):312-318. PubMed ID: 28105651
[TBL] [Abstract][Full Text] [Related]
16. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine and cisplatin combination chemotherapy in intrahepatic cholangiocarcinoma as second-line treatment: report of four cases.
Lee MA; Woo IS; Kang JH; Hong YS; Lee KS
Jpn J Clin Oncol; 2004 Sep; 34(9):547-50. PubMed ID: 15466829
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma.
Miura JT; Johnston FM; Tsai S; George B; Thomas J; Eastwood D; Banerjee A; Christians KK; Turaga KK; Pawlik TM; Clark Gamblin T
Ann Surg Oncol; 2015 Oct; 22(11):3716-23. PubMed ID: 25777092
[TBL] [Abstract][Full Text] [Related]
19. Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study.
Wang L; Deng M; Ke Q; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Zeng Y
Cancer Med; 2020 Apr; 9(8):2674-2685. PubMed ID: 32072774
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Propensity Score Survival Analysis Supporting Use in Patients with High-Risk Disease.
Utuama O; Permuth JB; Dagne G; Sanchez-Anguiano A; Alman A; Kumar A; Denbo J; Kim R; Fleming JB; Anaya DA
Ann Surg Oncol; 2021 Apr; 28(4):1939-1949. PubMed ID: 33415559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]